Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study.

Conclusions. Canadian AS patients were more likely to persist on therapy compared to Brazilian patients, although rates were lower at 2 years in both countries. Socioeconomic disparity in persistence was found in Brazil, but not in Quebec. PMID: 31990224 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31990224?dopt=Abstract

Source: Current Medical Research and Opinion - January 29, 2020 Category: Research Tags: Curr Med Res Opin Source Type: research